Synopsis
Motivation:
Goals:
Approach:
Results:
464-01-008
ISMRM Abstract
Cerebral Gray and White Matter Changes in Subjective Cognitive Decline Patients Based on DTI and 3D-T1WI Imaging
Accepted
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
Log inReferences
1. 2024 Alzheimer's disease facts and figures. Alzheimers Dement. 2024; 20(5):3708-821. doi:10.1002/alz.13809 [doi]
2. 2. Jack CR, Jr., Bennett DA, Blennow K, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018; 14(4):535-62. doi:10.1016/j.jalz.2018.02.018 [doi]
3. 3. Jack CR, Jr., Andrews JS, Beach TG, et al. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup. Alzheimers Dement. 2024; 20(8):5143-69. doi:10.1002/alz.13859 [doi]
4. 4. Jessen F, Amariglio RE, Buckley RF, et al. The characterisation of subjective cognitive decline. Lancet Neurol. 2020; 19(3):271-8. doi:10.1016/s1474-4422(19)30368-0 [doi]
5. 5. Goto M, Kamagata K, Andica C, et al. Deep Learning-based Hierarchical Brain Segmentation with Preliminary Analysis of the Repeatability and Reproducibility. Magn Reson Med Sci. 2025; 24(4). doi:10.2463/mrms.mp.2023-0124 [doi]
6. 6. Croall ID, Lohner V, Moynihan B, et al. Using DTI to assess white matter microstructure in cerebral small vessel disease (SVD) in multicentre studies. Clin Sci (Lond). 2017; 131(12):1361-73. doi:10.1042/cs20170146 [doi]
7. Rivas-Fernández M, Lindín M, Zurrón M, et al. Neuroanatomical and neurocognitive changes associated with subjective cognitive decline. Front Med (Lausanne). 2023; 10:1094799. doi:10.3389/fmed.2023.1094799 [doi]
8. 8. Cedres N, Diaz-Galvan P, Diaz-Flores L, et al. The interplay between gray matter and white matter neurodegeneration in subjective cognitive decline. Aging (Albany NY). 2021; 13(16):19963-77. doi:10.18632/aging.203467 [doi]
9. 9. Rao YL, Ganaraja B, Murlimanju BV, Joy T, Krishnamurthy A, Agrawal A. Hippocampus and its involvement in Alzheimer's disease: a review. 3 Biotech. 2022; 12(2):55. doi:10.1007/s13205-022-03123-4 [doi]
10. 10. Perosa V, Zanon Zotin MC, Schoemaker D, et al. Association Between Hippocampal Volumes and Cognition in Cerebral Amyloid Angiopathy. Neurology. 2024; 102(2):e207854. doi:10.1212/wnl.0000000000207854 [doi]
11. 11. Sinha N, Berg CN, Yassa MA, Gluck MA. Increased dynamic flexibility in the medial temporal lobe network following an exercise intervention mediates generalization of prior learning. Neurobiol Learn Mem. 2021; 177:107340. doi:10.1016/j.nlm.2020.107340 [doi]
12. 12. Baumeister H, Gellersen HM, Polk SE, et al. Disease stage-specific atrophy markers in Alzheimer's disease. Alzheimers Dement. 2025; 21(7):e70482. doi:10.1002/alz.70482 [doi]
13. 13. Zanon Zotin MC, Yilmaz P, Sveikata L, et al. Peak Width of Skeletonized Mean Diffusivity: A Neuroimaging Marker for White Matter Injury. Radiology. 2023; 306(3):e212780. doi:10.1148/radiol.212780 [doi]
14. 14. Baykara E, Gesierich B, Adam R, et al. A Novel Imaging Marker for Small Vessel Disease Based on Skeletonization of White Matter Tracts and Diffusion Histograms. Ann Neurol. 2016; 80(4):581-92. doi:10.1002/ana.24758 [doi]
15. 15. de Groot M, Verhaaren BF, de Boer R, et al. Changes in normal-appearing white matter precede development of white matter lesions. Stroke. 2013; 44(4):1037-42. doi:10.1161/strokeaha.112.680223 [doi]
Cite this abstract
http://echo.ismrm.org/p/ISMRM2026/464-01-008